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Background: Acute lower respiratory infections (ALRIs) are leading causes of hospitalisation in children. Birth
defects occur in 5% of live births in Western Australia (WA). The association between birth defects and ALRI
hospitalisation is unknown.
Methods: We conducted a retrospective cohort study of 245,249 singleton births in WA (1996-2005). Population-based
hospitalisation data were linked to the WA Register of Developmental Anomalies to investigate ALRI hospitalisations in
children with and without birth defects. We used negative binomial regression to estimate associations between birth
defects and number of ALRI hospitalisations before age 2 years, adjusting for known risk factors.
Results: Overall, 9% of non-Aboriginal children and 37% of Aboriginal children with birth defects had at least one
ALRI admission before age 2 years. Aboriginal children (IRR 2.3, 95% CI: 1.9-2.8) and non-Aboriginal children (IRR 2.0,
95% CI: 1.8-2.2) with birth defects had higher rates of hospitalisation for an ALRI than children with no birth defects.
Rates of ALRI hospitalisation varied by type of defect but were increased for all major birth defects categories, the
highest rate being for children with Down syndrome (IRR 8.0, 95% CI: 5.6-11.5). The rate of ALRI hospitalisation was
3 times greater in children with multiple birth defects than in those with isolated defects.
Conclusions: Children with birth defects experience higher rates of hospitalisation for ALRIs before age 2 years than
children with no birth defects. Optimal vaccination coverage and immunoprophylaxis for specific categories of birth
defects would assist in reducing hospitalisation rates for ALRI.
Keywords: Acute lower respiratory infections, Birth defects, Aboriginal Australian children, Linked population health
data, HospitalisationsBackground
Acute lower respiratory infections (ALRIs) are a major
cause of hospitalisation in young children [1]. Children
with pre-existing morbidities including birth defects are
at increased risk of hospitalisation for ALRI [2]. ALRIs
have been reported to be the most common reason
for hospitalisation in children with Down syndrome [3].
Children with birth defects such as congenital heart dis-
ease [4], Down syndrome [4,5], neuromuscular impair-
ment [4,6] and immunodeficiency [4], have been reported* Correspondence: hannah.moore@telethonkids.org.au
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unless otherwise stated.to be at increased risk of respiratory syncytial virus (RSV)-
associated morbidity and mortality [7,8]. However, to
our knowledge, there has been no study investigating
the risk of hospitalisation for all-cause ALRI associated
with a comprehensive range of isolated or multiple birth
defects.
ALRI hospitalisation rates are high among Indigenous
populations living in industrialised countries, including
Aboriginal Australians [9]. Recently, we reported that
the disparity for pneumonia hospitalisations between
Aboriginal and non-Aboriginal children had declined by
32-36% in Western Australia (WA) from 1996-2000 to
2001-2005 [10]. However, overall rates for ALRI remain
approximately 7 times higher in Aboriginal than non-
Aboriginal children in WA [10,11]. Known risk factorsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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autumn, gestational age less than 33 weeks, born by
elective caesarean section, mother who has had more than
3 previous pregnancies, maternal age less than 20 years,
low social economic status, residing in regional or remote
areas, percent optimal birthweight <85% and asthma or
smoking during pregnancy [11-15]. In WA, birth defects
occur in 5% of live births, and are important causes of
childhood morbidity [16,17]. However we do not know the
contribution of birth defects to the overall burden of ALRI
in WA.
We have previously used population-based linked
data from the Western Australian Data Linkage System
(WADLS) to investigate the burden and causal pathways
to ALRI hospitalisation in young children [9-11]. The
availability of the WA Register of Developmental Anom-
alies (WARDA) (formerly known as the WA Birth Defects
Registry), which is a state-based registry of birth defects
[18], offers a unique opportunity to investigate associa-
tions between a broad range of birth defects and hospital-
isation for ALRI in the entire population of WA. In this
study, population-based hospital morbidity data have been
linked to WARDA data to investigate ALRI hospitalisa-
tions in children with and without birth defects. We com-
pare the proportion of Aboriginal and non-Aboriginal
children with birth defects who were hospitalised for ALRI
with the proportion of children without birth defects hos-
pitalised for ALRI. Additionally, we investigate the rate of
ALRI hospitalisation in different diagnostic categories of
birth defects.
Methods
Setting and study population
WA covers an area of 2.5 million km2 and in 2005 had a
population of 2 million, 3% identifying as Aboriginal or
Torres Strait Islander [19].
Data extraction from the WA data linkage system
The WADLS has been operating since 1995. It consti-
tutes a powerful source for population-based research
on health outcomes, while overcoming limiting issues
relating to sample size and accurate exposure and out-
come ascertainment [20,21]. Linkage of administrative
health data is performed by the Data Linkage Branch
at the WA Department of Health using probabilistic
matching and clerical review with accuracy estimated to
be 99.9% [20]. These methods were used to extract infor-
mation on all 245,249 singleton live births in WA between
1996 and 2005 and their associated hospitalisations
for ALRI up to age 2 years and birth defects from the
Midwives’ Notification System, Birth and Death Register,
Hospital Morbidity Database System and WARDA. We re-
stricted our analysis to singleton births, as multiple births
may have different risk factors for ALRI than singletonbirths [11,22]. The study design, data extraction details and
definition of Aboriginality (Aboriginal or Torres Strait
Islander descent) have been described elsewhere [10,11].
ALRI hospitalisations
ICD10 codes were introduced in July 1999. Similar to
our previously published work [11], ICD9 codes for the
years 1996 to June 1999 were forward mapped to ICD10
codes using mapping tables provided by the Australian
National Centre for Classifications in Health. The prin-
cipal diagnosis code and 20 additional diagnosis codes
were used to identify ALRI admissions for the follow-
ing categories: acute bronchitis (J20), acute bronchiolitis
(J21), pneumonia (J12-J18, B59, B05.2, B37.1, B01.2), in-
fluenza (J10-J11), whooping cough (A37), and unspeci-
fied ALRI (J22) [11].
Birth defects
The WARDA has population-based information on birth
defects for all children born in WA since 1980 [18].
WARDA receives birth defect notifications from over
100 sources, including cytogenetics and ultrasound de-
partments, paediatricians, and all genetic counselling
clinics [17,18]. The Register definition of a birth defect
is one or more structural or functional anomalies that
are present at conception or occur before the end of
pregnancy and are diagnosed by 6 years of age. Each
birth defect (up to 10 per case) is coded according to the
5-digit British Paediatric Association ICD-9 system and
defects are grouped into major diagnostic categories
(nervous system defects, congenital anomalies (CA) of
eye, CA of ear, face and neck, cardiovascular defects,
respiratory system defects, gastrointestinal defects, uro-
genital defects, musculo-skeletal defects, CA of integu-
ment, chromosome defects, and all other defects). Each
birth defect is also classified as major or minor accord-
ing to a method developed by the Centers for Disease
Control and Prevention [17,18]. Most minor birth de-
fects are not recorded in the Register, unless requiring
treatment [17,18].
Statistical analysis
We used negative binomial regression to calculate inci-
dence rate ratios (IRR) with 95% confidence intervals
(CI) to estimate the association between categories of
birth defects (and selected individual birth defects likely
to affect the respiratory system) and the number of ALRI
hospitalisations during the first two years of life, adjust-
ing for sociodemographic characteristics that we previ-
ously identified as risk factors for ALRI and were also
potential confounders. These were gender, gestational age
(categorised as <33 weeks, 33-34, 35-36 or ≥ 37 weeks),
percent optimal birthweight [23] (categorised as <85%
(low), 85-114% (normal) or ≥ 115% (high)), number of
Table 1 Frequency of birth defects in Western Australian
Aboriginal and non-Aboriginal children by diagnostic
category (1996-2005)
Diagnostic category* Birth defects per 1000 births (n)
Aboriginal Non-Aboriginal
Uro-genital defects 9.5 (166) 17.2 (3910)
Musculo-skeletal defects 13.7 (240) 13.6 (3088)
Diaphragmatic hernia 0.6 (11) 0.2 (56)
Cardiovascular defects 11.6 (202) 10.5 (2393)
Ventricular septal defect 6.2 (109) 6.2 (1405)
Atrial septal defect 2.2 (39) 1.7 (383)
Nervous system defects 5.3 (92) 2.4 (542)
Spina bifida 0.7 (13) 0.2 (45)
CA of eye 1.3 (23) 1.1 (260)
CA of ear, face and neck 3.6 (63) 3.1 (703)
Respiratory system defects 0.9 (15) 0.6 (135)
Gastro-intestinal defects 5.3 (92) 5.5 (1248)
Cleft palate only 1.3 (22) 1.0 (234)
Cleft lip only 0.8 (14) 0.5 (106)
Cleft lip and palate 0.9 (15) 0.5 (113)
T-OF, OA/S 0.2 (4) 0.3 (59)
CA of integument 1.7 (30) 4.8 (1091)
Chromosome defects 1.7 (30) 2.0 (450)
Down syndrome 1.0 (18) 0.9 (211)
Other 9.3 (163) 5.7 (1288)
Cystic fibrosis 0.3 (6) 0.3 (79)
Note: numbers and proportions are in order of frequency of major birth defect
diagnostic categories.
*A child may be in more than one diagnostic category of major birth defects.
CA, Congenital Anomalies; T-OF, OA/S, Tracheo-oesophageal fistula,
oesophageal atresia/stenosis.
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maternal age (categorised as <20 years, 20-24, 25-29, 30-
34 or ≥ 35 years), maternal smoking and asthma during
pregnancy, socioeconomic status using the Socioeconomic
Index for Area (SEIFA codes, grouped into quantiles) and
the Accessibility/Remoteness Index of Australia (ARIA) as
a measure of residential remoteness (categorised as very
remote, remote, outer regional, inner regional or major
cities). SEIFA and ARIA scores were calculated at the col-
lection district level, a grouping of approximately 200
dwellings and the smallest unit available for population-
based analyses [11]. Information on maternal smoking
during pregnancy was added to the Midwives’ Notification
System in 1997 and therefore data prior to this time were
excluded from the regression models [11]. Time at risk
was calculated as the time period between date of birth
and the end of the study period (31st December 2005) or
death.
Unless otherwise specified, data for Aboriginal and
non-Aboriginal children were modelled separately due
to the considerable difference in ALRI hospitalisation
rates [11]. Chi-square comparisons between Aboriginal
and non-Aboriginal children related to frequency of birth
defect categories were conducted in EpiBasic (version 1.0).
All other analyses were conducted using SPSS statistics
software (version 19) and StataIC (version 11).
Ethics approval
Ethics approval to conduct the study was granted by
the Department of Health WA Human Research Ethics
Committee (DoHWA HREC), the Western Australian
Aboriginal Health and Information Ethics Committee
(WAAHIEC), and the Princess Margaret Hospital for
Children Ethics Committee. Access to linked data was
provided by the WA Department of Health. All data files
had identifying data removed before being provided to
the research team.
Results
Between 1996 and 2005 there were 13,316 (n = 5.4%)
live-born singleton children with birth defects from
the population of 245,249 singleton live births (4.7%
in Aboriginal children, 5.5% in non-Aboriginal children).
Overall, 11,977 (90%) had isolated birth defects, 1,331
(10%) had multiple birth defects and 8 cases were missing
information on their birth defects category. In addition
to Down syndrome, the birth defects most commonly
found as one of multiple defects were musculo-skeletal
defects, cardiovascular defects and CA of ear, face and
neck.
Table 1 shows in order of frequency the numbers and
proportions per 1000 births of Aboriginal and non-
Aboriginal children by major birth defect diagnostic
categories and subcategories. Uro-genital defects werethe most common birth defects in non-Aboriginal chil-
dren (17.2/1000 births, compared to 9.5/1000 births in
Aboriginal children, p < 0.001), while musculo-skeletal de-
fects were common among Aboriginal and non-Aboriginal
children (13.7/1000 births and 13.6/1000 births, p = 0.8), as
were cardiovascular defects (11.6/1000 Aboriginal births
and 10.5/1000 non-Aboriginal births, p = 0.2; Table 1).
Overall, 22.5% of Aboriginal children and 5.1% of non-
Aboriginal children were admitted at least once for ALRI
before age 2 years while 37.0% of Aboriginal children with
birth defects and 9.2% of non-Aboriginal children with
birth defects had at least one ALRI admission before age
2 years. Bronchiolitis accounted for 51% (n = 3178) and
pneumonia for 27% (n = 1711) of ALRI hospitalisations in
Aboriginal children aged less than 2 years; proportions in
non-Aboriginal children were 62% (n = 8407) for bronchio-
litis and 20% (n = 2724) for pneumonia. In Aboriginal chil-
dren the average length of stay during an ALRI episode in
those aged less than 2 years was 6.5 days in those with
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and 4.2 days in those with no birth defect. Equivalent
figures in non-Aboriginal children were 12.1, 5.9 and
3.2 days.
Both Aboriginal and non-Aboriginal children with birth
defects had twice the rate of hospitalisation for an ALRI
before age 2 years compared with Aboriginal and non-
Aboriginal children with no birth defects, after adjusting
for all known risk factors (Aboriginal IRR = 2.3; 95% CI 1.9,
2.8; non-Aboriginal IRR = 2.0, 95% CI 1.8, 2.2; Table 2).
To investigate any differences between types of ALRI,
we investigated the association between birth defects
and bronchiolitis and pneumonia. As the vast majority
of bronchiolitis hospitalisations occur in the first year of
life, the outcome for bronchiolitis was restricted to that
age group. The rates of admission for any ALRI before
age 2 years, bronchiolitis in the first year of life, or pneu-
monia before age 2 years were higher in Aboriginal and
non-Aboriginal children with multiple birth defects than
in those with isolated birth defects (Table 3). In parti-
cular, after adjusting for other known risk factors, there
was a strong positive association between multiple birth
defects and hospitalisation for pneumonia in the first
2 years of life in both Aboriginal (IRR = 5.0, 95% CI: 2.9,
8.6) and non-Aboriginal children (IRR = 6.0, 95% CI: 4.4,
8.2; Table 3).
Due to small numbers of individual birth defects in
the major categories and subcategories, we combined
data from Aboriginal and non-Aboriginal children to in-
vestigate the association between different types of birth
defects and ALRI hospitalisations. After adjusting for all
known risk factors, there was a positive association be-
tween all major categories of birth defects and hospi-
talisation for any ALRI in the first 2 years of life,
bronchiolitis in the first year of life and pneumonia in the
first 2 years of life (Table 4). There were particularly high
hospitalisation rates for pneumonia associated with Down
syndrome (IRR = 14) and with tracheo-oesophageal fistula,
oesophageal atresia/stenosis (IRR = 16), although the latter
was based on only 4 cases (Table 4). Separate analyses of
specific diagnoses of ALRI other than pneumonia or bron-
chiolitis was not possible due to limited numbers of cases.
Discussion
Using total population-based data, we have shown that
children in WA with any birth defect have a two-fold
higher rate of hospitalisation for ALRI in the first 2 years
of life than children with no birth defects. In addition, the
rates of hospitalisation for ALRI were higher in children
with multiple birth defects than children with isolated
birth defects. The rates were increased in all major birth
defect categories and for both bronchiolitis in the first year
of life and pneumonia before the age of two years. Our
findings are consistent with previously reported studiesthat have generally investigated a pathogen-specific ALRI
such as that caused by RSV or have only considered a spe-
cific birth defect or syndrome such as Down syndrome
[3,7]. To our knowledge, these population-based data are
the first contemporary findings to report the rate of hospi-
talisation for ALRI in both Aboriginal and non-Aboriginal
children with and without birth defects. Unlike other risk
factors we have reported previously [11], our results here
show remarkable similarities in the rate of hospitalisation
for ALRI with birth defects in both Aboriginal and non-
Aboriginal children.
There are a number of reasons why children with birth
defects are at increased rate of hospitalisation for ALRI
which will vary according to the type of birth defect.
There may be anatomical defects that increase risk of
pathogens entering the upper respiratory tract and lung,
they may be born preterm, of low birthweight and chil-
dren may have a compromised immune system making
them more susceptible to infection. Children with Down
syndrome may have abnormal airway anatomy, congeni-
tal heart disease and hypotonia impairing swallowing
and putting them at risk of aspiration. Surgery under an-
aesthetic increases risk of ALRI and many children with
birth defects require surgical management. For all these
reasons, unless specifically contraindicated, it is important
that children with birth defects receive vaccines according
to standard schedules, specifically pneumococcal, Hae-
mophilus influenzae type b, pertussis, measles and influ-
enza vaccines for prevention of ALRIs.
There are several limitations to our study. Firstly, our
linked hospitalisation data only included hospitalisations
with a respiratory infection diagnosis and not all admis-
sions for children with birth defects. Therefore, we do
not know whether the birth defects were surgically cor-
rected and, if so, whether this occurred prior to any hos-
pitalisations with a diagnosis of ALRI. Secondly, we do
not have information on other potential risk factors such
as breast feeding and duration of breast feeding, the
child’s immunisation status and child care attendance.
Lastly, we were unable to determine if and where indi-
viduals moved within or outside the state during the
study period. Therefore information related to socioeco-
nomic status and the accessibility/remoteness index may
have changed between the time of birth and time of hos-
pitalisation. However we believe this is likely to have had
little impact on our results [24] as, generally, our results
highlight information on maternal and infant factors in
the antenatal and natal period and analysis was re-
stricted to hospitalisations in the first 2 years of life and
we would not expect individuals to move very far from
their place of birth in their first 2 years of life. Despite
these limitations our study is total population-based and
provides important information that can assist in plan-
ning effective health care strategies based on individual
Table 2 Adjusted incidence rate ratio for ALRI
hospitalisations among children aged <2 years
according to risk factors
Risk factor Aboriginal Non-Aboriginal
IRR* (95% CI) IRR* (95% CI)
Any birth defect 2.3 (1.9, 2.8) 2.0 (1.8, 2.2)
Gender
Female Reference Reference
Male 1.4 (1.3, 1.5) 1.4 (1.3, 1.5)
Gestational age
≥37 weeks Reference Reference
35-36 weeks 1.5 (1.3, 1.8) 1.7 (1.5. 1.8)
33-34 weeks 1.7 (1.3, 2.3) 2.1 (1.7, 2.5)
<33 weeks 3.0 (2.4, 3.9) 4.6 (4.0, 5.4)
Percent optimal birthweight
Normal 85-114% Reference Reference
Low < 85% 1.1 (1.0, 1.2) 1.2 (1.1, 1.2)
High≥ 115% 1.0 (0.8, 1.2) 1.0 (0.9, 1.1)
Number of previous pregnancies
0 Reference Reference
1 1.0 (0.9, 1.2) 1.7 (1.5, 1.8)
2 1.4 (1.1, 1.6) 2.1 (1.9, 2.3)
≥ 3 1.7 (1.5, 2.0) 2.5 (2.4, 2.7)
Season of birth
Spring Reference Reference
Summer 1.3 (1.1, 1.5) 1.2 (1.1, 1.2)
Autumn 1.4 (1.2, 1.6) 1.5 (1.4, 1.6)
Winter 1.3 (1.1, 1.4) 1.3 (1.2, 1.4)
Mode of delivery
Vaginal Reference Reference
Instrumental 1.1 (0.9, 1.4) 1.0 (0.9, 1.0)
Elective caesarean 1.1 (0.9, 1.3) 1.3 (1.2, 1.4)
Emergency caesarean 1.1 (0.9, 1.3) 1.2 (1.1, 1.2)
Maternal smoking during pregnancy
No Reference Reference
Yes 1.2 (1.1, 1.4) 1.3 (1.2, 1.4)
Maternal asthma during pregnancy
No Reference Reference
Yes 1.1 (0.9, 1.3) 1.5 (1.4, 1.5)
Maternal age
≥ 35 years Reference Reference
30-34 years 1.0 (0.8, 1.3) 1.2 (1.1, 1.3)
25-29 years 1.3 (1.0, 1.6) 1.6 (1.4, 1.7)
20-24 years 1.5 (1.2, 1.9) 2.0 (1.8, 2.2)
< 20 years 2.0 (1.6, 2.6) 2.7 (2.4, 3.1)
SEIFA Index of disadvantage**
91-100% Reference Reference
Table 2 Adjusted incidence rate ratio for ALRI
hospitalisations among children aged <2 years
according to risk factors (Continued)
76-90% 0.9 (0.3, 2.4) 1.1 (1.0, 1.3)
26-75% 1.5 (0.6, 3.7) 1.2 (1.0, 1.3)
11-25% 1.5 (0.6, 3.8) 1.3 (1.2, 1.5)
0-10% 1.8 (0.7, 4.3) 1.4 (1.2, 1.6)
Accessibility/Remoteness index
of Australia
Very remote Reference Reference
Remote 0.6 (0.5, 0.7) 1.5 (1.1, 1.9)
Outer regional 0.7 (0.6, 0.8) 1.7 (1.3, 2.2)
Inner regional 0.5 (0.4, 0.6) 1.1 (0.8, 1.5)
Major cities 0.5 (0.4, 0.6) 1.2 (0.9, 1.6)
*IRR, incidence rate ratio.
**91-100% is least disadvantaged and 0-10% is most disadvantaged.
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vention of hospitalisations for ALRI among children
with birth defects. We would now encourage other re-
search groups with access to administrative health care
datasets similar to these to replicate the analyses we
have conducted here which will provide further evidence
to assist in planning future health care strategies for
children with birth defects.
Immunoprophylaxis with the RSV monoclonal antibody,
palivizumab, is effective in reducing severe RSV-related
hospitalisations, mostly associated with bronchiolitis and
pneumonia [25]. Palivizumab has also been found to re-
duce the risk of hospitalisations in babies with congenital
heart disease and monthly immunoprophylaxis is now rec-
ommended for infants with congenital heart disease or
chronic lung disease [25]. Our results provide further evi-
dence to support such recommendations since children
with congenital heart defects were more than twice as
likely to be hospitalised for bronchiolitis in the first year of
life and for pneumonia in the first 2 years of their life than
children with no birth defects. In WA during the period of
our study palivizumab was prescribed on a case-by-case
basis, but since 2009 has been recommended during the
RSV season for children with severe cardiac conditions
and it is currently being considered for those with chronic
respiratory conditions as well. While the cost of palivizu-
mab is high, in view of the increased risk of hospitalisation
for bronchiolitis and pneumonia in children with birth de-
fects, consideration should be given to offering palivizu-
mab prophylaxis to children with serious birth defects,
particularly those with multiple defects. From our findings
we suggest randomised controlled trials should be con-
ducted to determine whether immunoprophylaxis for
children with nervous system defects, congenital anom-
alies of ear, face and neck, trachea-oesophageal fistulae
Table 3 Adjusted incidence rate ratio for ALRI hospitalisations in children with isolated or multiple birth defects (BDs)
Hospitalisation diagnosis Aboriginal Non- Aboriginal
Isolated BDs Multiple BDs Isolated BDs Multiple BDs
IRR* (95%CI) IRR* (95%CI) IRR* (95%CI) IRR* (95%CI)
Any ALRI <24 months 2.0 (1.6, 2.5) 3.4 (2.3, 5.0) 1.8 (1.6, 1.9) 4.4 (3.6, 5.4)
Bronchiolitis <12 months 2.0 (1.5, 2.7) 1.7 (1.0, 3.0) 1.5 (1.4, 1.7) 3.4 (2.6, 4.4)
Pneumonia <24 months 1.5 (1.0, 2.2) 5.0 (2.9, 8.6) 1.8 (1.5, 2.1) 6.0 (4.4, 8.2)
*IRR, incidence rate ratio.
For each model, the reference group is children with no birth defects.
Adjusted for gender, gestational age, season of birth, mode of delivery, number previous pregnancies, per cent optimal birthweight (POBW), maternal age,
maternal asthma during pregnancy, maternal smoking during pregnancy, and socioeconomic indices for areas accessibility/remoteness index of Australia [11].
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phragmatic hernia and any chromosomal defect is effective
in reducing hospitalisations for bronchiolitis or pneumonia.
Any such trial is likely to be difficult due to the large sam-
ple size that will be needed to adequately detect a signifi-
cant difference. A further consideration is that prophylaxis
should be restricted to the months with high rates of RSV
infection to reduce cost, and timing will vary according to
geographic location and climate [26].Table 4 Adjusted incidence rate ratio for ALRI hospitalisation
birth defect diagnostic category
Diagnostic category Any ALRI
<24 months
IRR* (95% CI)
Uro-genital defects 1.6 (1.3, 1.8)
Musculo-skeletal defects 1.8 (1.5, 2.1)
Diaphragmatic hernia 2.4 (0.9, 6.4)
Cardiovascular defects 3.1 (2.7, 3.6)
Ventricular septal defect 2.6 (2.2, 3.2)
Atrial septal defect 4.7 (3.4, 6.3)
Nervous system defects 3.3 (2.5, 4.3)
Spina bifida 2.9 (0.9, 9.4)
CA of eye 3.4 (2.2, 5.2)
CA of ear, face and neck 4.5 (3.6, 5.6)
Respiratory system defects 2.9 (1.6, 5.0)
Gastro-intestinal defects 2.2 (1.8, 2.7)
Cleft palate only 2.2 (1.3, 3.6)
Cleft lip only 0.5 (0.1, 1.6)
Cleft lip and palate 2.5 (1.2, 4.8)
T-OF, OA/S 7.4 (3.1, 17.7)
CA of integument 1.6 (1.2, 2.1)
Chromosome defects 6.7 (5.1, 8.7)
Down syndrome 8.0 (5.6, 11.5)
*IRR, incidence rate ratio.
**too few cases for analysis.
For each model, the reference group is children with no birth defects.
Adjusted for gender, gestational age, season of birth, mode of delivery, number pre
maternal asthma during pregnancy, maternal smoking during pregnancy, and socio
CA, Congenital Anomalies; T-OF, OA/S, Tracheo-oesophageal fistula, oesophageal atConclusions
In summary this total population-based study has pro-
vided useful information on the rate of hospitalisation
for ALRI for a broad range of birth defects in Aboriginal
and non-Aboriginal Australian children. Primary preven-
tion of and prenatal screening for birth defects, optimal
vaccination coverage and immunoprophylaxis for specific
categories of birth defects will assist in reducing hospital-
isation rates for ALRI.s in Aboriginal and non-Aboriginal children according to
Bronchiolitis Pneumonia
<12 months <24 months
IRR* (95% CI) IRR* (95% CI)
1.4 (1.1, 1.6) 1.4 (1.0, 1.8)
1.6 (1.3, 1.9) 1.9 (1.4, 2.5)
1.5 (0.3, 7.5) 4.3 (1.1, 16.7)
2.5 (2.0, 3.0) 3.3 (2.6, 4.2)
2.2 (1.6, 2.8) 2.7 (1.9, 3.8)
2.8 (1.7, 4.3) 6.9 (4.4, 10.8)
2.4 (1.6, 3.5) 4.4 (2.8, 6.7)
4.3 (1.1, 15.9) - -**
1.9 (1.0, 3.6) 4.9 (2.5, 9.3)
3.9 (2.9, 6.3) 4.2 (2.8, 6.4)
1.8 (0.8, 4.0) 3.6 (1.5, 8.9)
1.9 (1.4, 2.6) 2.6 (1.7, 3.8)
2.2 (1.1, 4.2) 1.7 (0.6, 4.8)
- -** 1.4 (0.3, 6.0)
4.0 (1.9, 8.6) 0.9 (0.1, 6.9)
3.5 (0.9, 13.1) 15.8 (5.1, 48.6)
1.9 (1.3, 2.6) 1.1 (0.6, 2.0)
4.7 (3.2, 6.8) 9.9 (6.7, 14.4)
5.4 (3.3, 9.0) 13.6 (8.4, 21.9)
vious pregnancies, per cent optimal birthweight (POBW), maternal age,
economic indices for areas accessibility/remoteness index of Australia [11].
resia/stenosis.
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